LENZ CIK: 1815776

LENZ Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−52.9
FY22:
−88.0
FY23:
−60.4
FY24:
−59.4
FY25:
−69.2
Change from FY21 to FY25
millions USD
FY21:
−5.74
FY22:
−242
FY23:
−29.6
FY24:
−154
FY25:
−75.7
Change from FY21 to FY25
millions USD
FY21:
417
FY22:
0.60
FY23:
80.7
FY24:
199
FY25:
150
millions USD
FY21:
359
FY22:
−329
FY23:
−9.30
FY24:
−14.9
FY25:
4.91
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.6
FY22:
−94.6
FY23:
−60.4
FY24:
−59.9
FY25:
−70.0

All amounts in millions USD Data source:SEC EDGAR